Video Latest - ecancer

The CAR T cell revolution in cancer therapy

Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA

23 Sep 2016

Development of a novel CD19 CAR with improved functionality

Anne Kramer - PhD student, University College London, London, UK

23 Sep 2016

Immune strategies for treating neuroblastoma

Dr Karin Straathof - UCL Institute of Child Health, London, UK

23 Sep 2016

Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL

Dr Sara Ghorashian - University College London, London, UK

23 Sep 2016

Developments in checkpoint immunotherapy

Dr James Larkin - The Royal Marsden NHS Foundation Trust, London, UK

22 Sep 2016

Targetted medicine to reduce melanoma mutational burden

Prof Grant McArthur - The Royal Melbourne Hospital, Melbourne, Australia

22 Sep 2016

VISMO trial to treat basal cell carcinoma

Prof Axel Hauschild - University of Kiel, Kiel, Germany

22 Sep 2016

Checkpoint inhibitor therapy for treating melanoma

Dr Jeffrey Weber - Perlmutter Cancer Center, New York, USA

22 Sep 2016

Tumour heterogeneity and the impact on patient care

Dr Nicholas McGranahan - The Francis Crick Institute, London, UK

14 Sep 2016

Understanding the mechanisms of immunotherapy in lung cancer

Dr Rafael Rosell - Catalan Institute of Oncology, Barcelona, Spain

14 Sep 2016

PDL1 and other biomarkers for selecting patients for immune checkpoint therapies

Dr Mary O'Brien - The Royal Marsden NHS Foundation Trust, London, UK

14 Sep 2016

Editor's Choice for August 2016

Prof Gordon McVie - Editor in Chief, ecancer

22 Aug 2016

Video